Cargando…
QTc prolongation assessment in anticancer drug development: clinical and methodological issues
Cardiac safety assessments are commonly employed in the clinical development of investigational oncology medications. In anti-cancer drug development there has been increasing consideration for the potential of a compound to cause adverse electrocardiographic changes, especially QT interval prolonga...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cancer Intelligence
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223992/ https://www.ncbi.nlm.nih.gov/pubmed/22275999 http://dx.doi.org/10.3332/ecancer.2009.130 |